Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

SPDR S&P Pharmaceuticals (ETF) (NYSEMKT:XPH.DL)

CAPS Rating: No stars

Exchange traded fund

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:XPH.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

RPMick (89.75)
Submitted July 21, 2008

Targeting pharmaceuticals, this ETF has 21 holdings w/ none representing more than 7% of the fund. A current $.10 per share dividend and an expense ratio of just .35.Drug innovation has only begun and instead of targeting the one or two in the… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NYSEMKT:XPH.DL VS S&P 500 (SPY)

NYSEMKT:XPH.DL Summary

  • ETF Category:
  • ETF Type:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about XPH.DL.

No one has written a Pitch for XPH.DL stock yet. Tell us why you think XPH.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in XPH.DL.

No players have picked XPH.DL yet. Tell us why you think XPH.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for XPH.DL.